These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1517388)

  • 1. Alterations in spontaneous growth hormone (GH) secretion and the response to GH-releasing hormone in children with nonorganic nutritional dwarfing.
    Abdenur JE; Pugliese MT; Cervantes C; Fort P; Lifshitz F
    J Clin Endocrinol Metab; 1992 Sep; 75(3):930-4. PubMed ID: 1517388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulated growth hormone (GH) secretion in children with delays in pubertal development before and after the onset of puberty: relationship with peripheral plasma GH-releasing hormone and somatostatin levels.
    Saggese G; Cesaretti G; Giannessi N; Bracaloni C; Cinquanta L; Cioni C
    J Clin Endocrinol Metab; 1992 Feb; 74(2):272-8. PubMed ID: 1346143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion.
    Eakman GD; Dallas JS; Ponder SW; Keenan BS
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1217-23. PubMed ID: 8772602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
    Guzzaloni G; Grugni G; Morabito F
    Minerva Endocrinol; 1998 Dec; 23(4):99-104. PubMed ID: 10361807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum immunoreactive and bioactive growth hormone concentrations in boys with advancing puberty and in response to a 20-hour estradiol infusion.
    Cemeroglu AP; Barkan AL; Kletter GB; Beitins IZ; Foster CM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2166-71. PubMed ID: 9215289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal growth hormone (GH) response to GH-releasing hormone in children with thalassemia major before puberty: a possible age-related effect.
    Leger J; Girot R; Crosnier H; Postel-Vinay MC; Rappaport R
    J Clin Endocrinol Metab; 1989 Aug; 69(2):453-6. PubMed ID: 2502556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone.
    Racine MS; Symons KV; Foster CM; Barkan AL
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3326-31. PubMed ID: 15240610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A persistent pattern of varying pituitary responsivity to exogenous growth hormone (GH)-releasing hormone in GH-deficient children: evidence supporting periodic somatostatin secretion.
    Martha PM; Blizzard RM; McDonald JA; Thorner MO; Rogol AD
    J Clin Endocrinol Metab; 1988 Sep; 67(3):449-54. PubMed ID: 2900843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatotropic function in short stature: evaluation by integrated auxological and hormonal indices in 214 children. The Italian Collaborative Group of Neuroendocrinology.
    Dammacco F; Boghen MF; Camanni F; Cappa M; Ferrari C; Ghigo E; Giordano G; Loche S; Minuto F; Mucci M
    J Clin Endocrinol Metab; 1993 Jul; 77(1):68-72. PubMed ID: 8325962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
    Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal release of immunoreactive growth hormone-releasing hormone and growth hormone in normal children.
    Tapanainen P; Rantala H; Leppäluoto J; Lautala P; Käär ML; Knip M
    Pediatr Res; 1989 Nov; 26(5):404-9. PubMed ID: 2510118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
    Gelato MC; Malozowski S; Caruso-Nicoletti M; Ross JL; Pescovitz OH; Rose S; Loriaux DL; Cassorla F; Merriam GR
    J Clin Endocrinol Metab; 1986 Jul; 63(1):174-9. PubMed ID: 3086356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atenolol enhances nocturnal growth hormone (GH) release in GH-deficient children during long term GH-releasing hormone therapy.
    Martha PM; Blizzard RM; Thorner MO; Rogol AD
    J Clin Endocrinol Metab; 1990 Jan; 70(1):56-61. PubMed ID: 2104629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.
    Loche S; Cambiaso P; Carta D; Setzu S; Imbimbo BP; Borrelli P; Pintor C; Cappa M
    J Clin Endocrinol Metab; 1995 Feb; 80(2):674-8. PubMed ID: 7852535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature.
    Ghigo E; Mazza E; Imperiale E; Rizzi G; Benso L; Müller EE; Camanni F; Massara F
    J Clin Endocrinol Metab; 1987 Sep; 65(3):452-6. PubMed ID: 3114300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
    Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
    Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation.
    Zadik Z; Chalew SA; Kowarski A
    J Clin Endocrinol Metab; 1990 Oct; 71(4):932-6. PubMed ID: 2205627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.